Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Cools

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|December 14, 2011
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patientsEllen Van Gulck, Erika Vlieghe, Marc Vekemans, et al.
Scientific Reports|October 15, 2020
A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammationCedric Joossen, Adrienn Baán, Carlos Moreno-Cinos, et al.
Transplantation|July 23, 2014
Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cellsAmaryllis H Van Craenenbroeck, Evelien L J Smits, Sébastien Anguille, et al.
Global Change Biology|May 6, 2024
Widespread breakdown in masting in European beech due to rising summer temperaturesJessie J Foest, Michał Bogdziewicz, Mario B Pesendorfer, et al.
Ambio|October 3, 2023
Publisher Correction: Leveraging research infrastructure co-location to evaluate constraints on terrestrial carbon cycling in northern European forestsMartyn N Futter, Thomas Dirnböck, Martin Forsius, et al.
Ambio|September 19, 2023
Leveraging research infrastructure co-location to evaluate constraints on terrestrial carbon cycling in northern European forestsMartyn N Futter, Thomas Dirnböck, Martin Forsius, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Science Translational Medicine|September 11, 2015
Hurdles in therapy with regulatory T cellsPiotr Trzonkowski, Rosa Bacchetta, Manuela Battaglia, et al.
The Science of the Total Environment|December 2, 2021
Simulating tree growth response to climate change in structurally diverse oak and beech forestsLouis de Wergifosse, Frédéric André, Hugues Goosse, et al.
BMJ Open|March 19, 2024
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in BelgiumToon Van Genechten, Maxime De Laere, Jolien Van den Bossche, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|December 14, 2011
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patientsEllen Van Gulck, Erika Vlieghe, Marc Vekemans, et al.
Scientific Reports|October 15, 2020
A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammationCedric Joossen, Adrienn Baán, Carlos Moreno-Cinos, et al.
Transplantation|July 23, 2014
Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cellsAmaryllis H Van Craenenbroeck, Evelien L J Smits, Sébastien Anguille, et al.
Global Change Biology|May 6, 2024
Widespread breakdown in masting in European beech due to rising summer temperaturesJessie J Foest, Michał Bogdziewicz, Mario B Pesendorfer, et al.
Ambio|October 3, 2023
Publisher Correction: Leveraging research infrastructure co-location to evaluate constraints on terrestrial carbon cycling in northern European forestsMartyn N Futter, Thomas Dirnböck, Martin Forsius, et al.
Ambio|September 19, 2023
Leveraging research infrastructure co-location to evaluate constraints on terrestrial carbon cycling in northern European forestsMartyn N Futter, Thomas Dirnböck, Martin Forsius, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Science Translational Medicine|September 11, 2015
Hurdles in therapy with regulatory T cellsPiotr Trzonkowski, Rosa Bacchetta, Manuela Battaglia, et al.
The Science of the Total Environment|December 2, 2021
Simulating tree growth response to climate change in structurally diverse oak and beech forestsLouis de Wergifosse, Frédéric André, Hugues Goosse, et al.
BMJ Open|March 19, 2024
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in BelgiumToon Van Genechten, Maxime De Laere, Jolien Van den Bossche, et al.
Pageof 11